Humana and Evolent Expand Partnership to Enhance Oncology Care
Partnership Focuses on Improving Prior Authorization Process, Helping Drive Better Patient Outcomes
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241107578119/en/
“This partnership underscores our commitment to delivering a better healthcare experience and, most importantly, better health outcomes for our members,”
said
Humana is working to simplify the prior authorization process by leveraging Evolent's advanced technology platform and expertise across the patient’s cancer journey. Through the Evolent platform, providers can access the most up-to-date, clinically appropriate therapy choices for specific clinical scenarios. Prior authorization requests are submitted in minutes and approvals are delivered in seconds. This connected experience, which is well organized, simple to navigate and CMS compliant, will reduce administrative burdens for both providers and patients and ensure that Humana members receive timely access to high-quality care.
“We are thrilled to continue partnering with Humana to drive meaningful change across the continuum of oncology care,”
said
Under the expanded partnership, Evolent will serve as Humana's designated utilization management and pathway vendor for radiation and surgical oncology services. The partnership represents a significant milestone in modernizing authorization processes and underscores both companies' dedication to improving healthcare outcomes.
About Humana
About Evolent
Evolent (NYSE: EVH) specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable. Evolent serves a national base of leading payers and providers and is consistently recognized as a top place to work in health care nationally. Learn more about how Evolent is changing the way health care is delivered by visiting evolent.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241107578119/en/
Evolent:
jmanfuso@evolent.com
Humana:
Ksmith305@humana.com
Source: